Compared with the anti-VEGF group, the ICIs group had a higher cumulative incidence of sustained AKI in one year before PS matching (26.8% vs. 17.8%, P < 0.001) or after PS matching (26.1% vs. 17.8%, P < 0.001) (Fig. 2). Here, VEGFA is linked to acute kidney injury.